世界中医药
文章摘要
引用本文:李萌1,柏兆方2,章从恩1,马致洁1.复方益肝灵胶囊预防抗结核药物性肝损伤的血清学指标Meta分析[J].世界中医药,2021,(13):.  
复方益肝灵胶囊预防抗结核药物性肝损伤的血清学指标Meta分析
Meta-analysis of Fufang Yiganling Capsules against Serum Makers of Anti-tuberculosis Drug-induced Liver Injury
投稿时间:2019-08-04  
DOI:10.3969/j.issn.1673-7202.2021.13.011
中文关键词:  复方益肝灵胶囊  肺结核  肝损伤  预防  血清指标  Meta分析
English Keywords:Fufang Yiganling Capsules  Tuberculosis  Liver injury  Precaution  Serum indexes  Meta-analysis
基金项目:国家“重大新药创制”科技重大专项(2017ZX09301022)
作者单位
李萌1,柏兆方2,章从恩1,马致洁1 1 首都医科大学附属北京友谊医院中药剂科北京100050 2 解放军总医院第五医学中心北京100039 
摘要点击次数: 321
全文下载次数: 0
中文摘要:
      目的:通过Meta分析方法,系统评价复方益肝灵胶囊在预防抗结核药物肝损伤方面的临床疗效。方法:通过检索国家知识基础设施数据库(CNKI)、中国学术期刊数据库(CSPD)、中文科技期刊数据库(CCD)、中国生物医学文献数据库(CBMdisc)及PubMed数据库,收集复方益肝灵胶囊在预防抗结核药物肝损伤方面的临床随机对照试验数据,通过RevMan 5.3软件进行Meta分析。结果:共纳入文献9篇,累计患者1 674例。Meta分析结果显示,复方益肝灵胶囊可显著降低谷草转氨酶(MD=-14.78,95%CI为-21.36~-8.21,P<0.000 1)、谷丙转氨酶(MD=-4.31,95%CI为-7.09~-1.52,P=0.002)、总胆红素(MD=-1.31,95%CI为-3.44~0.83,P=0.001)水平,可显著降低肝损伤率(MD=0.37,95%CI为0.30~0.45,P<0.000 01)。结论:复方益肝灵胶囊预防抗结核药物肝损伤疗效确切。
English Summary:
      We systematically evaluated the clinical efficacy of Fufang Yiganling Capsules in the prevention of anti-tuberculosis drug-induced liver injury by Meta-analysis system.Methods:Randomized controlled trials of oral Fufang Yiganling Capsules in the prevention of anti-tuberculosis drug-induced liver injury were collected by searching China National Knowledge Infrastructure(CNKI),China Science Periodical Database(CSPD),Chinese Citation Database(CCD),China Biology Medicine disc(CBMdisc) and PubMed databases.Meta-analysis was performed by RevMan 5.3 software.Results:A total of 9 pieces of literature were included,with a total of 1 674 patients.Meta-analysis showed that Fufang Yiganling Capsules was able to decrease the levels of Aspartate aminotransferase[MD=-14.78,95%CI(-21.36 to -8.21),P<0.000 1],Alanine aminotransferase[MD=-4.31,95%CI(-7.09 to -1.52),P=0.002] and Total bilirubin[MD=-1.31,95%CI(-3.44 to 0.83),P=0.001] significantly,thereby reducing the rate of liver injury[MD=0.37,95%CI(0.30 to 0.45),P<0.000 01] significantly.Conclusion:Fufang Yiganling Capsules in the prevention of anti-tuberculosis drug-induced liver injury had definite curative effects.
查看全文  查看/发表评论  下载PDF阅读器